AUGMENTIN

Product NDC: 43598-012
11-digit product format: 435980012
Labeler code: 43598
Product ID: 43598-012_81f11e22-8d19-4974-87d5-aa983d5ea945
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: amoxicillin and clavulanate potassium
Dosage form: POWDER, FOR SUSPENSION
Route: ORAL
Labeler: Dr. Reddy's Laboratories Inc
Application: NDA050575
Marketing category: NDA
Marketing start: 1990-10-22
Marketing end: 0000-00-00
Substance: AMOXICILLIN; CLAVULANATE POTASSIUM
Active strength: 125 mg/5mL; mg/5mL
Pharmacologic classes: Penicillin-class Antibacterial [EPC],Penicillins [CS],beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA]
NDC exclude flag: E
Listing certified through: 2018-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 8 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	43598-012		D	Discontinued by firm	2026-10-05
excluded product	product	43598-012		I	Inactivated by FDA	2026-10-05
excluded package	package	43598-012	43598-012-51	D	Discontinued by firm	2026-10-05
excluded package	package	43598-012	43598-012-52	D	Discontinued by firm	2026-10-05
excluded package	package	43598-012	43598-012-53	D	Discontinued by firm	2026-10-05
excluded package	package	43598-012	43598-012-51	I	Inactivated by FDA	2026-10-05
excluded package	package	43598-012	43598-012-52	I	Inactivated by FDA	2026-10-05
excluded package	package	43598-012	43598-012-53	I	Inactivated by FDA	2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 3 · 136 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	43598-012-53	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	43598-012-52	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	43598-012-52	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	43598-012-53	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	43598-012-51	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	43598-012-51	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	43598-012-53	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	43598-012-52	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	43598-012-52	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	43598-012-53	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	43598-012-51	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	43598-012-51	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	43598-012-53	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	43598-012-52	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	43598-012-52	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	43598-012-53	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	43598-012-51	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	43598-012-51	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	43598-012-53	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	43598-012-52	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	43598-012-52	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	43598-012-53	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	43598-012-51	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	43598-012-51	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	43598-012-53	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	43598-012-52	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	43598-012-52	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	43598-012-53	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	43598-012-51	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	43598-012-51	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	43598-012-53	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	43598-012-52	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	43598-012-52	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	43598-012-53	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	43598-012-51	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	43598-012-51	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	43598-012-53	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	43598-012-52	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	43598-012-52	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	43598-012-53	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	43598-012-51	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	43598-012-51	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	43598-012-53	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	43598-012-52	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N050575-001	AUGMENTIN '125'	AMOXICILLIN; CLAVULANATE POTASSIUM	125MG/5ML;EQ 31.25MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	1984-08-06
N050575-002	AUGMENTIN '250'	AMOXICILLIN; CLAVULANATE POTASSIUM	250MG/5ML;EQ 62.5MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD, RS	1984-08-06

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
N050575-001	AB
N050575-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N050575-001	AUGMENTIN '125'	125MG/5ML;EQ 31.25MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	1984-08-06	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N050575-002	AUGMENTIN '250'	250MG/5ML;EQ 62.5MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD, RS	1984-08-06	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N050575-001	AUGMENTIN '125'	125MG/5ML;EQ 31.25MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	1984-08-06	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N050575-002	AUGMENTIN '250'	250MG/5ML;EQ 62.5MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD, RS	1984-08-06	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N050575-001	AUGMENTIN '125'	125MG/5ML;EQ 31.25MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	1984-08-06	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N050575-002	AUGMENTIN '250'	250MG/5ML;EQ 62.5MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD, RS	1984-08-06	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N050575-001	AUGMENTIN '125'	125MG/5ML;EQ 31.25MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	1984-08-06	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N050575-002	AUGMENTIN '250'	250MG/5ML;EQ 62.5MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD, RS	1984-08-06	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N050575-001	AUGMENTIN '125'	125MG/5ML;EQ 31.25MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	1984-08-06	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N050575-002	AUGMENTIN '250'	250MG/5ML;EQ 62.5MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD, RS	1984-08-06	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N050575-001	AUGMENTIN '125'	125MG/5ML;EQ 31.25MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	1984-08-06	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N050575-002	AUGMENTIN '250'	250MG/5ML;EQ 62.5MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD, RS	1984-08-06	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N050575-001	AUGMENTIN '125'	125MG/5ML;EQ 31.25MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	1984-08-06	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N050575-002	AUGMENTIN '250'	250MG/5ML;EQ 62.5MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD, RS	1984-08-06	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N050575-001	AUGMENTIN '125'	125MG/5ML;EQ 31.25MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	1984-08-06	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N050575-002	AUGMENTIN '250'	250MG/5ML;EQ 62.5MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD, RS	1984-08-06	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N050575-001	AUGMENTIN '125'	125MG/5ML;EQ 31.25MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	1984-08-06	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N050575-002	AUGMENTIN '250'	250MG/5ML;EQ 62.5MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD, RS	1984-08-06	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N050575-001	AUGMENTIN '125'	125MG/5ML;EQ 31.25MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	1984-08-06	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N050575-002	AUGMENTIN '250'	250MG/5ML;EQ 62.5MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD, RS	1984-08-06	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N050575-001	AUGMENTIN '125'	125MG/5ML;EQ 31.25MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	1984-08-06	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N050575-002	AUGMENTIN '250'	250MG/5ML;EQ 62.5MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD, RS	1984-08-06	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N050575-001	AUGMENTIN '125'	125MG/5ML;EQ 31.25MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	1984-08-06	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N050575-002	AUGMENTIN '250'	250MG/5ML;EQ 62.5MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD, RS	1984-08-06	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N050575-001	AUGMENTIN '125'	125MG/5ML;EQ 31.25MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	1984-08-06	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N050575-002	AUGMENTIN '250'	250MG/5ML;EQ 62.5MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD, RS	1984-08-06	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N050575-001	AUGMENTIN '125'	125MG/5ML;EQ 31.25MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	1984-08-06	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N050575-002	AUGMENTIN '250'	250MG/5ML;EQ 62.5MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD, RS	1984-08-06	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N050575-001	AUGMENTIN '125'	125MG/5ML;EQ 31.25MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	1984-08-06	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N050575-002	AUGMENTIN '250'	250MG/5ML;EQ 62.5MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD, RS	1984-08-06	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N050575-001	AUGMENTIN '125'	125MG/5ML;EQ 31.25MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	1984-08-06	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N050575-002	AUGMENTIN '250'	250MG/5ML;EQ 62.5MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD, RS	1984-08-06	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N050575-001	AUGMENTIN '125'	125MG/5ML;EQ 31.25MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	1984-08-06	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N050575-002	AUGMENTIN '250'	250MG/5ML;EQ 62.5MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD, RS	1984-08-06	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N050575-001	AUGMENTIN '125'	125MG/5ML;EQ 31.25MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	1984-08-06	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N050575-002	AUGMENTIN '250'	250MG/5ML;EQ 62.5MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD, RS	1984-08-06	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N050575-001	AUGMENTIN '125'	125MG/5ML;EQ 31.25MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	1984-08-06	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N050575-002	AUGMENTIN '250'	250MG/5ML;EQ 62.5MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD, RS	1984-08-06	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N050575-001	AUGMENTIN '125'	125MG/5ML;EQ 31.25MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD	1984-08-06	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N050575-002	AUGMENTIN '250'	250MG/5ML;EQ 62.5MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RLD, RS	1984-08-06	`74a2ff9319b5…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	N050575-001	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N050575-002	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N050575-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N050575-002	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N050575-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N050575-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N050575-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N050575-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N050575-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N050575-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N050575-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N050575-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N050575-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N050575-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N050575-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N050575-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N050575-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N050575-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N050575-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N050575-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N050575-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N050575-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N050575-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N050575-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N050575-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N050575-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N050575-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N050575-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N050575-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N050575-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N050575-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N050575-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N050575-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N050575-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N050575-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N050575-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N050575-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N050575-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N050575-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N050575-002	AB	1	`74a2ff9319b5…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
502415e5-4ac7-4266-a01a-ef44aa3c028d	Product name	7	20250623
d0f377c9-74d8-e2e3-e06e-4d37534f5c0f	Product name	3	20250620
2ebbc361-d28f-48a9-a286-c1ae09cdaf5c	Product name	3	20230314
2bb254ff-3d7f-4bdb-abf9-476506008c55	Product name	1	20230117
a62a50ac-1535-4461-9768-8ae703e2e9fb	Product name	1	20210525
f33561b9-47cb-411c-a228-16c62e346cd4	Product name	1	20200415
8690a824-4bf8-4d1e-b118-2d6dda86bc04	Product name	2	20161206
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877	Product name	1	20140508
bc07ef78-e82d-0c19-31f4-31f263780582	Product name	1	20140508
cf3f1c02-1f32-2322-3314-b70ebbf5610e	Product name	1	20140508
ebb3e917-326a-9e18-0354-a19c9f63a2f3	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
43598-012-51	2020-01-31	C162847	48780-1	9d75b9d0-fca3-f424-e053-dadaa90a57ce	These highlights do not include all the information needed to use AUGMENTIN safely and effectively. See full prescribing information for AUGMENTIN. AUGMENTIN ® (amoxicillin/clavulanate potassium) Tablets, Powder for Oral Suspension, and Chewable Tablets Initial U.S. Approval: 1984 To reduce the development of drug-resistant bacteria and maintain the effectiveness of AUGMENTIN and other antibacterial drugs, AUGMENTIN should be used only to treat infections that are proven or strongly suspected to be caused b
43598-012-52	2020-01-31	C162847	48780-1	9d75b9d0-fca3-f424-e053-dadaa90a57ce	These highlights do not include all the information needed to use AUGMENTIN safely and effectively. See full prescribing information for AUGMENTIN. AUGMENTIN ® (amoxicillin/clavulanate potassium) Tablets, Powder for Oral Suspension, and Chewable Tablets Initial U.S. Approval: 1984 To reduce the development of drug-resistant bacteria and maintain the effectiveness of AUGMENTIN and other antibacterial drugs, AUGMENTIN should be used only to treat infections that are proven or strongly suspected to be caused b
43598-012-53	2020-01-31	C162847	48780-1	9d75b9d0-fca3-f424-e053-dadaa90a57ce	These highlights do not include all the information needed to use AUGMENTIN safely and effectively. See full prescribing information for AUGMENTIN. AUGMENTIN ® (amoxicillin/clavulanate potassium) Tablets, Powder for Oral Suspension, and Chewable Tablets Initial U.S. Approval: 1984 To reduce the development of drug-resistant bacteria and maintain the effectiveness of AUGMENTIN and other antibacterial drugs, AUGMENTIN should be used only to treat infections that are proven or strongly suspected to be caused b

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
43598-012-51	AUGMENTIN	75 mL in 1 BOTTLE	POWDER, FOR SUSPENSION	75	6
43598-012-52	AUGMENTIN	100 mL in 1 BOTTLE	POWDER, FOR SUSPENSION	100	6
43598-012-53	AUGMENTIN	150 mL in 1 BOTTLE	POWDER, FOR SUSPENSION	150	6

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
43598-012-51	ML - Milliliter	43598-012	73c20da8-74d1-4789-9c42-08cb20d767cf	1	2012-07-24
43598-012-52	ML - Milliliter	43598-012	63af0fff-dab7-48ef-a25c-989827b66d18	1	2012-07-24
43598-012-53	ML - Milliliter	43598-012	50731d85-d4c5-4520-9f93-8bbaedb58208	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
AMOXICILLIN	ACTIVE INGREDIENT	804826J2HU	AUGMENTIN (AMOXICILLIN AND CLAVULANATE POTASSIUM) TABLET, FILM COATED AUGMENTIN (AMOXICILLIN AND CLAVULANATE POTASSIUM) POWDER, FOR SUSPENSION [DR. REDDY'S LABORATORIES INC]	5
CLAVULANATE POTASSIUM	ACTIVE INGREDIENT	Q42OMW3AT8	AUGMENTIN (AMOXICILLIN AND CLAVULANATE POTASSIUM) TABLET, FILM COATED AUGMENTIN (AMOXICILLIN AND CLAVULANATE POTASSIUM) POWDER, FOR SUSPENSION [DR. REDDY'S LABORATORIES INC]	5
AMOXICILLIN ANHYDROUS	ACTIVE MOIETY	9EM05410Q9	AUGMENTIN (AMOXICILLIN AND CLAVULANATE POTASSIUM) TABLET, FILM COATED AUGMENTIN (AMOXICILLIN AND CLAVULANATE POTASSIUM) POWDER, FOR SUSPENSION [DR. REDDY'S LABORATORIES INC]	5
CLAVULANIC ACID	ACTIVE MOIETY	23521W1S24	AUGMENTIN (AMOXICILLIN AND CLAVULANATE POTASSIUM) TABLET, FILM COATED AUGMENTIN (AMOXICILLIN AND CLAVULANATE POTASSIUM) POWDER, FOR SUSPENSION [DR. REDDY'S LABORATORIES INC]	5
ASPARTAME	INACTIVE INGREDIENT	Z0H242BBR1	AUGMENTIN (AMOXICILLIN AND CLAVULANATE POTASSIUM) TABLET, FILM COATED AUGMENTIN (AMOXICILLIN AND CLAVULANATE POTASSIUM) POWDER, FOR SUSPENSION [DR. REDDY'S LABORATORIES INC]	5
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	AUGMENTIN (AMOXICILLIN AND CLAVULANATE POTASSIUM) TABLET, FILM COATED AUGMENTIN (AMOXICILLIN AND CLAVULANATE POTASSIUM) POWDER, FOR SUSPENSION [DR. REDDY'S LABORATORIES INC]	5
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	AUGMENTIN (AMOXICILLIN AND CLAVULANATE POTASSIUM) TABLET, FILM COATED AUGMENTIN (AMOXICILLIN AND CLAVULANATE POTASSIUM) POWDER, FOR SUSPENSION [DR. REDDY'S LABORATORIES INC]	5
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	AUGMENTIN (AMOXICILLIN AND CLAVULANATE POTASSIUM) TABLET, FILM COATED AUGMENTIN (AMOXICILLIN AND CLAVULANATE POTASSIUM) POWDER, FOR SUSPENSION [DR. REDDY'S LABORATORIES INC]	5
MANNITOL	INACTIVE INGREDIENT	3OWL53L36A	AUGMENTIN (AMOXICILLIN AND CLAVULANATE POTASSIUM) TABLET, FILM COATED AUGMENTIN (AMOXICILLIN AND CLAVULANATE POTASSIUM) POWDER, FOR SUSPENSION [DR. REDDY'S LABORATORIES INC]	5
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	AUGMENTIN (AMOXICILLIN AND CLAVULANATE POTASSIUM) TABLET, FILM COATED AUGMENTIN (AMOXICILLIN AND CLAVULANATE POTASSIUM) POWDER, FOR SUSPENSION [DR. REDDY'S LABORATORIES INC]	5
SACCHARIN SODIUM DIHYDRATE	INACTIVE INGREDIENT	SB8ZUX40TY	AUGMENTIN (AMOXICILLIN AND CLAVULANATE POTASSIUM) TABLET, FILM COATED AUGMENTIN (AMOXICILLIN AND CLAVULANATE POTASSIUM) POWDER, FOR SUSPENSION [DR. REDDY'S LABORATORIES INC]	5
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	AUGMENTIN (AMOXICILLIN AND CLAVULANATE POTASSIUM) TABLET, FILM COATED AUGMENTIN (AMOXICILLIN AND CLAVULANATE POTASSIUM) POWDER, FOR SUSPENSION [DR. REDDY'S LABORATORIES INC]	5
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	AUGMENTIN (AMOXICILLIN AND CLAVULANATE POTASSIUM) TABLET, FILM COATED AUGMENTIN (AMOXICILLIN AND CLAVULANATE POTASSIUM) POWDER, FOR SUSPENSION [DR. REDDY'S LABORATORIES INC]	5
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	AUGMENTIN (AMOXICILLIN AND CLAVULANATE POTASSIUM) TABLET, FILM COATED AUGMENTIN (AMOXICILLIN AND CLAVULANATE POTASSIUM) POWDER, FOR SUSPENSION [DR. REDDY'S LABORATORIES INC]	5
XANTHAN GUM	INACTIVE INGREDIENT	TTV12P4NEE	AUGMENTIN (AMOXICILLIN AND CLAVULANATE POTASSIUM) TABLET, FILM COATED AUGMENTIN (AMOXICILLIN AND CLAVULANATE POTASSIUM) POWDER, FOR SUSPENSION [DR. REDDY'S LABORATORIES INC]	5

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
43598-012	AUGMENTIN (AMOXICILLIN AND CLAVULANATE POTASSIUM) TABLET, FILM COATED AUGMENTIN (AMOXICILLIN AND CLAVULANATE POTASSIUM) POWDER, FOR SUSPENSION [DR. REDDY'S LABORATORIES INC]	6	Legacy NDC, 3 package rows	20160913_174cc098-fe49-4f1a-87e2-601c7573f0db.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Augmentin	AMOXICILLIN AND CLAVULANATE POTASSIUM	Allegis Holdings, LLC	04a31a42-d79e-bbb4-e063-6394a90a63ee	2024-05-16	Warnings, Adverse reactions	Exact identifier application applno (NDA): 050575 application number: NDA050575

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
804826J2HU	AMOXICILLIN	61336-70-7	AMOXICILLIN
Q42OMW3AT8	CLAVULANATE POTASSIUM	61177-45-5	CLAVULANATE POTASSIUM

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
617302	amoxicillin 125 MG / clavulanic acid 31.25 MG in 5 mL Oral Suspension	PSN	174cc098-fe49-4f1a-87e2-601c7573f0db	6
562251	amoxicillin 250 MG / clavulanate potassium 125 MG Oral Tablet	PSN	174cc098-fe49-4f1a-87e2-601c7573f0db	6
617322	amoxicillin 250 MG / clavulanic acid 62.5 MG in 5 mL Oral Suspension	PSN	174cc098-fe49-4f1a-87e2-601c7573f0db	6
617296	amoxicillin 500 MG / clavulanate potassium 125 MG Oral Tablet	PSN	174cc098-fe49-4f1a-87e2-601c7573f0db	6
562508	amoxicillin 875 MG / clavulanate potassium 125 MG Oral Tablet	PSN	174cc098-fe49-4f1a-87e2-601c7573f0db	6
617333	AUGMENTIN 125 MG / 31.25 MG in 5 mL Oral Suspension	PSN	174cc098-fe49-4f1a-87e2-601c7573f0db	6
824186	AUGMENTIN 250 MG / 125 MG Oral Tablet	PSN	174cc098-fe49-4f1a-87e2-601c7573f0db	6
617339	AUGMENTIN 250 MG / 62.5 MG in 5 mL Oral Suspension	PSN	174cc098-fe49-4f1a-87e2-601c7573f0db	6
824190	AUGMENTIN 500 MG / 125 MG Oral Tablet	PSN	174cc098-fe49-4f1a-87e2-601c7573f0db	6
824194	AUGMENTIN 875 MG / 125 MG Oral Tablet	PSN	174cc098-fe49-4f1a-87e2-601c7573f0db	6
617333	amoxicillin 25 MG/ML / clavulanate 6.25 MG/ML Oral Suspension [Augmentin]	SBD	174cc098-fe49-4f1a-87e2-601c7573f0db	6
824186	amoxicillin 250 MG / clavulanate 125 MG Oral Tablet [Augmentin]	SBD	174cc098-fe49-4f1a-87e2-601c7573f0db	6
617339	amoxicillin 50 MG/ML / clavulanate 12.5 MG/ML Oral Suspension [Augmentin]	SBD	174cc098-fe49-4f1a-87e2-601c7573f0db	6
824190	amoxicillin 500 MG / clavulanate 125 MG Oral Tablet [Augmentin]	SBD	174cc098-fe49-4f1a-87e2-601c7573f0db	6
824194	amoxicillin 875 MG / clavulanate 125 MG Oral Tablet [Augmentin]	SBD	174cc098-fe49-4f1a-87e2-601c7573f0db	6
617302	amoxicillin 25 MG/ML / clavulanate 6.25 MG/ML Oral Suspension	SCD	174cc098-fe49-4f1a-87e2-601c7573f0db	6
562251	amoxicillin 250 MG / clavulanate 125 MG Oral Tablet	SCD	174cc098-fe49-4f1a-87e2-601c7573f0db	6
617322	amoxicillin 50 MG/ML / clavulanate 12.5 MG/ML Oral Suspension	SCD	174cc098-fe49-4f1a-87e2-601c7573f0db	6
617296	amoxicillin 500 MG / clavulanate 125 MG Oral Tablet	SCD	174cc098-fe49-4f1a-87e2-601c7573f0db	6
562508	amoxicillin 875 MG / clavulanate 125 MG Oral Tablet	SCD	174cc098-fe49-4f1a-87e2-601c7573f0db	6
617302	amoxicillin (as amoxicillin trihydrate) 25 MG/ML / clavulanate (as clavulanate potassium) 6.25 MG/ML Oral Suspension	SY	174cc098-fe49-4f1a-87e2-601c7573f0db	6
562251	amoxicillin (as amoxicillin trihydrate) 250 MG / clavulanic acid (as clavulanate potassium) 125 MG Oral Tablet	SY	174cc098-fe49-4f1a-87e2-601c7573f0db	6
617322	amoxicillin (as amoxicillin trihydrate) 250 MG / clavulanic acid (as clavulanate potassium) 62.5 MG per 5 Oral Suspension	SY	174cc098-fe49-4f1a-87e2-601c7573f0db	6
617296	amoxicillin (as amoxicillin trihydrate) 500 MG / clavulanic acid (as clavulanate potassium) 125 MG Oral Tablet	SY	174cc098-fe49-4f1a-87e2-601c7573f0db	6
562508	amoxicillin (as amoxicillin trihydrate) 875 MG / clavulanic acid (as clavulanate potassium) 125 MG Oral Tablet	SY	174cc098-fe49-4f1a-87e2-601c7573f0db	6
617302	amoxicillin 125 MG / clavulanic acid 31.25 MG per 5 ML Oral Suspension	SY	174cc098-fe49-4f1a-87e2-601c7573f0db	6
617322	amoxicillin 250 MG / clavulanic acid 62.5 MG per 5 ML Oral Suspension	SY	174cc098-fe49-4f1a-87e2-601c7573f0db	6
617333	Augmentin (amoxicillin 125 MG / clavulanate 31.25 MG) per 5 ML Oral Suspension	SY	174cc098-fe49-4f1a-87e2-601c7573f0db	6
617339	Augmentin (amoxicillin 250 MG / clavulanate 62.5 MG) per 5 ML Oral Suspension	SY	174cc098-fe49-4f1a-87e2-601c7573f0db	6
617333	Augmentin 125 MG / 31.25 MG per 5 ML Oral Suspension	SY	174cc098-fe49-4f1a-87e2-601c7573f0db	6
617339	Augmentin 250 mg / 62.5 MG per 5 ML Oral Suspension	SY	174cc098-fe49-4f1a-87e2-601c7573f0db	6
824186	Augmentin 250-mg Oral Tablet	SY	174cc098-fe49-4f1a-87e2-601c7573f0db	6
824190	Augmentin 500-mg Oral Tablet	SY	174cc098-fe49-4f1a-87e2-601c7573f0db	6
824194	Augmentin 875-mg Oral Tablet	SY	174cc098-fe49-4f1a-87e2-601c7573f0db	6

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
43598-012-51	43598001251	75 mL in 1 BOTTLE	75 ml	Historical
43598-012-52	43598001252	100 mL in 1 BOTTLE	100 ml	Historical
43598-012-53	43598001253	150 mL in 1 BOTTLE	150 ml	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
AUGMENTIN	Dr. Reddy's Laboratories Inc \| Dr. Reddy's Laboratories Inc DBA Dr. Reddy's Laboratories Tennessee LLC \| Beecham Pharmaceuticals (PTE) Limited \| SmithKline Beecham Limited	2016-09-01	HUMAN PRESCRIPTION DRUG LABEL	6